Pieris Pharmaceuticals
Boston, US · Founded 2013 · Nevada corporation · 1 known investors
Founders & leadership
DD
Darlene Deptula-HicksExecutive
SS
Stephen S. YoderExecutive
DM
Darlene M. Deptula-HicksActing Chief Financial Officer
CT
Christina TakkeNamed on SEC filing
Board
CK
SP
Steven PrelackBoard director
MR
Michael RichmanBoard director
JB
Jean-Pierre BizzariBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$102.1M disclosed across 4 rounds · 2014–2019
▶$32MraisedNov 2019 · 9 investors · PharmaceuticalsRule 506(b)
▶$32MraisedNov 2019 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Stephen S. YoderExecutive Officer, Director
- Ahmed MousaExecutive Officer
- James GeraghtyDirector
- Michael RichmanDirector
- Ann Barbier, M.D., Ph.D.Director
- Hitto Kaufmann, Ph.D.Executive Officer
- Christopher KiritsyDirector
- Peter Kiener, D.Phil.Director
- Matthew L. Sherman, M.D.Director
- Maya R. Said, Sc.D.Director
- Tom BuresExecutive Officer
- Jean-Pierre Bizzari, M.D.Director
- Offering amount
- $32M
- Amount sold
- $32M
- Sales commissions
- $796.1K
- Placement agents
- William Blair & Company
- First sale
- Nov 2019
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$16.5MraisedJun 2016 · 15 investors · BiotechnologyRule 506(b)
▶$16.5MraisedJun 2016 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Darlene Deptula-HicksExecutive Officer
- Steven PrelackDirector
- Chau KhuongDirector
- Michael RichmanDirector
- Stephen S. YoderExecutive Officer, Director
- Jean-Pierre BizzariDirector
- Offering amount
- $16.5M
- Amount sold
- $16.5M
- Sales commissions
- $1.1M
- Placement agents
- Trout Capital LLC, Oppenheimer & Co. Inc., Cowen and Company, LLC
- First sale
- Jun 2016
- Incorporated
- Corporation, Nevada, 2013
- Federal exemptions
- 06b
▶$13.6MraisedDec 2014 · 139 investors · PharmaceuticalsRule 506(b)
▶$13.6MraisedDec 2014 · 139 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Chau KhuongDirector
- Darlene M. Deptula-HicksExecutive Officer
- Steven PrelackDirector
- Christina TakkeDirector
- Michael RichmanDirector
- Stephen S. YoderExecutive Officer, Director
- Offering amount
- $13.6M
- Amount sold
- $13.6M
- Minimum investment
- $2K
- Sales commissions
- $1M
- Placement agents
- Trout Capital LLC, Dinosaur Securities, L.L.C., American Portfolios Financial Services, Inc.
- First sale
- Dec 2014
- Incorporated
- Corporation, Nevada, 2013
- Federal exemptions
- 06b
▶$40MraisedDec 2014 · 21 investors · PharmaceuticalsRule 506(b)
▶$40MraisedDec 2014 · 21 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael RichmanDirector
- Christina TakkeDirector
- Chau KhuongDirector
- Darlene M. Deptula-HicksExecutive Officer
- Steven PrelackDirector
- Stephen S. YoderExecutive Officer, Director
- Offering amount
- $40M
- Amount sold
- $40M
- First sale
- Dec 2014
- Incorporated
- Corporation, Nevada, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Pieris Pharmaceuticals's investors?
- Pieris Pharmaceuticals's investors include OrbiMed.
- How much funding has Pieris Pharmaceuticals raised?
- Pieris Pharmaceuticals has disclosed $102.1M raised across 4 rounds.
- Where is Pieris Pharmaceuticals headquartered?
- Pieris Pharmaceuticals is headquartered in Boston, US.